I’ve got no problem accepting the diagnosis. With time I’ve taken to heart my 94-year-old father’s attitude to the way the ...

Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety Demonstrated greater α-synuclein ...